Conference Coverage
Conference Coverage
SGLT2 inhibitors, developed for T2D, now ‘belong to cardiologists and nephrologists’
When the SGT2 inhibitor drugs first came to the U.S. market they were labeled for just treating hyperglycemia, but those days are over.
Conference Coverage
Novel program cuts weight retention after gestational diabetes
Postpartum, web-based weight loss program called “Balance After Baby” reduces weight retention in women with prior gestational diabetes.
Conference Coverage
Intermittent fasting ‘not benign’ for patients with diabetes
The “big issue” for such individuals who undertake intermittent fasting is hypoglycemia, so caloric restriction may be a better choice for some...
Conference Coverage
How many hormones make an ideal ‘artificial pancreas?’
Several automated insulin delivery systems in development add glucagon and/or pramlintide to insulin, but are they worth the extra cost and effort...
Conference Coverage
Cognitive deficits complex in youths with type 2 diabetes
Average fluid cognition scores were significantly lower versus youths with type 1 diabetes, a difference investigators said was due to further...
Conference Coverage
Dapagliflozin benefits low-EF heart failure regardless of diuretic dose: DAPA-HF
The trial that turned an SGLT2 inhibitor into a heart failure drug also has clues to mechanisms behind the observed benefits. Contrary to early...
Conference Coverage
Diabetes control in U.S. youth has worsened over time
Among American children, adolescents, and young adults with type 1 and type 2 diabetes, blood glucose control hasn’t improved in almost 20 years...
Conference Coverage
Diabetes-related amputations on the rise in older adults
The finding reflects increases in diabetes-related nontraumatic lower extremity amputation occurring in younger U.S. population, but at a less...
Conference Coverage
Normal-weight prediabetes patients also benefit from lifestyle intervention
Conference Coverage
T2D plus heart failure packs a deadly punch
Medical records from 150,000 Danish patients with type 2 diabetes showed heart failure comorbidity was the deadliest combination.